Ligand Pharmaceuticals
LGND
#3459
Rank
C$5.46 B
Marketcap
C$273.92
Share price
-2.12%
Change (1 day)
66.00%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): C$88.66 Million

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are C$0.25 Billion. In 2024 the company made an earning of C$7.53 Million a decrease over its 2023 earnings that were of C$87.25 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$88.66 M1077.37%
2024 C$7.53 M-91.37%
2023 C$87.25 M-7.59%
2022 C$94.42 M4%
2021 C$90.79 M296.42%
2020 C$22.9 M-97.97%
2019 C$1.12 B275.62%
2018 C$0.30 B237.48%
2017 C$89.08 M49.05%
2016 C$59.76 M55.41%
2015 C$38.45 M36.87%
2014 C$28.09 M29.59%
2013 C$21.68 M1309.35%
2012 C$1.53 M-43.97%
2011 C$2.74 M-113.19%
2010 -C$20.82 Million59.86%
2009 -C$13.03 Million-61.33%
2008 -C$33.68 Million-58.75%
2007 -C$81.64 Million20.52%
2006 -C$67.75 Million81.27%
2005 -C$37.38 Million
2003 -C$26.02 Million-20.6%
2002 -C$32.77 Million4.38%
2001 -C$31.39 Million-48.83%
2000 -C$61.35 Million-19.74%
1999 -C$76.43 Million-19.06%
1998 -C$94.43 Million126.71%
1997 -C$41.66 Million-5.83%
1996 -C$44.23 Million136.23%
1995 -C$18.73 Million-33.97%
1994 -C$28.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$43.95 B 48,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.07 B 17,644.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$30.53 B 33,591.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$11.18 B 12,242.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-C$0.37 Billion-504.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$31.32 B 34,469.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$10.89 B 11,926.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$12.64 B 13,857.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-C$83.96 Million-192.65%๐Ÿ‡บ๐Ÿ‡ธ USA